PP
ECTE

Paloma Partners’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

Paloma Partners’s Portfolio ECTE Stock Details ECTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-17,236
Closed -$43K – 1358
2013
Q2 		$43K Buy
+17,236
New +$90.4K ﹤0.01% 1109

Other funds holding ECTE

PM
Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EEG
E.E. Geduld $178M AUM 29.34% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NPC
National Planning Corporation El Segundo, California $726K AUM 14.28% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Paloma Partners's ECTE Position: Q3 2013 in Review

Paloma Partners sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q3 2013, closing a stake of 17,236 shares — an estimated $43K sold.

Paloma Partners first reported a position in ECTE in Q2 2013 and held it in 1 quarter. The position peaked at $43K in Q2 2013. 23 funds tracked by Wall St. Rank hold ECTE as of Q3 2013.

  • Paloma Partners reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q3 2013 after selling out during the quarter.
  • Paloma Partners sold 17,236 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q3 2013, an estimated $43K.
  • Paloma Partners first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q2 2013 and held it in 1 quarter.
  • Paloma Partners's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $43K in Q2 2013.
  • 23 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q3 2013.

Based on Paloma Partners's 13F filing for Q3 2013, filed 14 Nov 2013.